On Friday, Century Therapeutics Inc (NASDAQ: IPSC) was -3.17% drop from the session before settling in for the closing price of $1.26. A 52-week range for IPSC has been $1.14 – $5.51.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -14.25%. When this article was written, the company’s average yearly earnings per share was at 30.50%. With a float of $34.38 million, this company’s outstanding shares have now reached $60.34 million.
Considering the fact that the conglomerate employs 165 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is -404.17%, operating margin of -4925.59%, and the pretax margin is -4869.53%.
Century Therapeutics Inc (IPSC) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Century Therapeutics Inc stocks. The insider ownership of Century Therapeutics Inc is 59.56%, while institutional ownership is 29.37%. The most recent insider transaction that took place on Nov 04 ’24, was worth 1,267. In this transaction Chief Operations Officer of this company sold 1,033 shares at a rate of $1.23, taking the stock ownership to the 135,130 shares. Before that another transaction happened on Nov 04 ’24, when Company’s SVP Finance & Operations sold 283 for $1.23, making the entire transaction worth $347. This insider now owns 317,147 shares in total.
Century Therapeutics Inc (IPSC) Earnings and Forecasts
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.46 earnings per share (EPS) during the time that was better than consensus figure (set at -0.53) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.44 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 30.50% per share during the next fiscal year.
Century Therapeutics Inc (NASDAQ: IPSC) Trading Performance Indicators
You can see what Century Therapeutics Inc (IPSC) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 10.39. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 37.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.86, a number that is poised to hit -0.41 in the next quarter and is forecasted to reach -1.76 in one year’s time.
Technical Analysis of Century Therapeutics Inc (IPSC)
Compared to the last year’s volume of 0.27 million, its volume of 0.5 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 22.49%. Additionally, its Average True Range was 0.13.
During the past 100 days, Century Therapeutics Inc’s (IPSC) raw stochastic average was set at 3.72%, which indicates a significant decrease from 18.63% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 84.61% in the past 14 days, which was lower than the 88.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4875, while its 200-day Moving Average is $2.7289. Nevertheless, the first resistance level for the watch stands at $1.2867 in the near term. At $1.3533, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.3967. If the price goes on to break the first support level at $1.1767, it is likely to go to the next support level at $1.1333. Should the price break the second support level, the third support level stands at $1.0667.
Century Therapeutics Inc (NASDAQ: IPSC) Key Stats
There are 85,029K outstanding shares of the company, which has a market capitalization of 100.45 million. As of now, sales total 2,240 K while income totals -136,670 K. Its latest quarter income was 790 K while its last quarter net income were -31,230 K.
